Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Nymox Pharmaceutical Corporation : Nymox Announces Positive Safety Monitoring Committee Results for Phase 3 NX-1207 Trials for BPH
Nymox Pharmaceutical Corporation : Nymox Announces Positive Safety Monitoring Committee Results for Phase 3 NX-1207 Trials for BPH
Nymox Pharmaceutical Corporation : Nymox Announces Positive Safety Monitoring Committee Results for Phase 3 NX-1207 Trials for BPH
Submitted by
admin
on April 28, 2012 - 12:57pm
Source:
4-Traders
News Tags:
Nymox
NX-1207
benign prostatic hyperplasia
BPH
Headline:
Nymox Pharmaceutical Corporation : Nymox Announces Positive Safety Monitoring Committee Results for Phase 3 NX-1207 Trials for BPH
Do Not Allow Advertisers to Use My Personal information
